Literature DB >> 28188091

A prospective, multicenter analysis of pseudocapsule characteristics: Do all stages of renal cell carcinoma have complete pseudocapsules?

Seok Cho1, Jeong Hyeon Lee2, Seung Hyun Jeon3, Jinsung Park4, Sang Hyub Lee3, Chul Hwan Kim2, Ji-Youn Sung5, Joo Heon Kim6, Jong Hyun Pyun1, Jeong Gu Lee1, Je Jong Kim1, Jun Cheon1, Sung Gu Kang1, Seok Ho Kang7.   

Abstract

OBJECTIVES: To assess the characteristics of pseudocapsule (PC) in localized renal cell carcinoma (RCC) by analyzing the rates of completeness of PC and pseudocapsular invasion and clinical and pathological risk factors of it.
MATERIALS AND METHODS: Between February 2013 and September 2015, data were gathered prospectively from 180 consecutive patients who underwent partial nephrectomy or radical nephrectomy at 3 institutions, and 161 were enrolled. Evaluated factors included age and sex; histologic factors such as tumor diameter, stage, tumor subtype, necrosis, and Fuhrman grade; and clinical factors such as RENAL score; and completeness of PC.
RESULTS: Only 94 tumors (58.4%) were surrounded by a continuous PC completely, 62 (38.5%) were partially surrounded, and 5 (3.1%) had no PC. Overall, 56 PCs (34.8%) were free from invasion, 58 PCs (36.0%) had partial invasion of PC without parenchymal invasion, and 47 PCs (29.2%) had parenchymal invasion. Defining parenchymal invasion as true pseudocapsular invasion, histologic diameter, RCC subtype, and completeness of PC were significant predictors for parenchymal invasion on multivariate analysis (P = 0.006, 0.046, and 0.002, respectively).
CONCLUSIONS: Rate of complete PC in RCC is relatively low in this study. The risk factors for pseudocapsular invasion were a histologic diameter greater than 4cm, non-clear cell histology, and an incomplete PC. Surgeons must prepare for the possibility of a positive surgical margin if a tumor has at least one of these risk factors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Kidney neoplasms; Partial nephrectomy; Pseudocapsule

Mesh:

Year:  2017        PMID: 28188091     DOI: 10.1016/j.urolonc.2017.01.003

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  6 in total

1.  [Clinical and pathological analysis of small renal cell carcinoma].

Authors:  X P Zhang; Z X Huang; L P Yu; X W Zhang; Q Li; S J Liu; T Xu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

2.  Are nephrometry scores enough to select patients really fit for nephron sparing surgery?

Authors:  Francesco Porpiglia; Daniele Amparore; Angela Pecoraro; Enrico Checcucci
Journal:  Ann Transl Med       Date:  2019-09

3.  Is Preoperative Magnetic Resonance Imaging in a Daily Clinical Setting Useful to Evaluate Tumor Invasion Beyond the Pseudocapsule in Renal Cell Carcinoma?

Authors:  Hideto Iwamoto; Kanae Nosaka; Hidenao Miyoshi; Karen Makishima; Ryouya Ochiai; Ryutarou Shimizu; Tetsuya Yumioka; Shuichi Morizane; Masashi Honda; Atsushi Takenaka
Journal:  Yonago Acta Med       Date:  2021-11-29       Impact factor: 1.641

4.  A preoperative nomogram predicting the pseudocapsule status in localized renal cell carcinoma.

Authors:  Jiao Hu; Jinbo Chen; Huihuang Li; Tongchen He; Hao Deng; Guanghui Gong; Yu Cui; Peihua Liu; Wenbiao Ren; Xu Zhou; Chao Li; Xiongbing Zu
Journal:  Transl Androl Urol       Date:  2020-04

5.  CT-Based Radiomics Signature for Preoperative Prediction of Coagulative Necrosis in Clear Cell Renal Cell Carcinoma.

Authors:  Kai Xu; Lin Liu; Wenhui Li; Xiaoqing Sun; Tongxu Shen; Feng Pan; Yuqing Jiang; Yan Guo; Lei Ding; Mengchao Zhang
Journal:  Korean J Radiol       Date:  2020-06       Impact factor: 3.500

6.  No Detection of Pseudocapsule of Tumor-Parenchyma Interface on Multidetector Computed Tomography (MDCT) Images: Clinical Significance and Histological Reflections in Renal Cell Carcinoma.

Authors:  Wei Xi; Qinxuan Tan; Yingyong Hou; Xiaoyi Hu; Hang Wang; Li Liu; Yu Xia; Qi Bai; Jiajun Wang; Jianjun Zhou; Jianming Guo
Journal:  Cancer Manag Res       Date:  2021-07-06       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.